CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
601607 Shanghai Pharmaceuticals Holding
- 17.96
- -0.02-0.11%
Market Closed Apr 30 15:00 CST
66.60BMarket Cap15.34P/E (TTM)
18.08High17.92Low63.66KlotVolume18.00Open17.98Pre Close114.44MTurnover0.23%Turnover Ratio14.63P/E (Static)3.71BShares23.2052wk High0.91P/B50.09BFloat Cap17.2852wk Low19.78Limit Up2.79BShs Float27.89Historical High16.18Limit Down0.89%Amplitude-2.54Historical Low0.49Dividend TTM17.98Avg Price34.94KlotAsk2.73%Div YieldTTM100Lot Size26.71KlotBid
Shanghai Pharmaceuticals Holding Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 20.39%36.17B | 17.13%35.74B | 15.58%33.82B | 17.04%36.68B | 11.09%30.04B | 11.37%30.52B | 14.80%29.26B | 17.38%31.34B | -26.18%27.04B | 22.38%27.4B |
| Transactional financial assets | 24.23%8.86B | -14.96%8.63B | -24.91%8.56B | -37.27%7.18B | -35.54%7.14B | 5.60%10.15B | -9.37%11.4B | 7.90%11.44B | --11.07B | --9.61B |
| Notes receivable and accounts receivable | 4.10%86.34B | 7.23%80.25B | 9.12%84.49B | 4.86%82.66B | 8.73%82.94B | 9.16%74.84B | 5.44%77.43B | 18.91%78.82B | 18.01%76.28B | 15.45%68.56B |
| -Notes receivable | -41.67%988.49M | -41.21%1.12B | 11.73%1.42B | 21.23%1.71B | 21.70%1.69B | 6.06%1.91B | 7.63%1.27B | 16.06%1.41B | 18.96%1.39B | 40.72%1.8B |
| -Accounts receivable | 5.06%85.35B | 8.49%79.13B | 9.08%83.07B | 4.56%80.95B | 8.49%81.25B | 9.25%72.93B | 5.40%76.16B | 18.96%77.41B | 18.00%74.89B | 14.89%66.76B |
| Other receivables (including interest and dividends) | 9.93%3.25B | -8.12%3.11B | 16.71%3.19B | -2.69%3.43B | 20.19%2.96B | 31.32%3.38B | 23.00%2.73B | 13.09%3.53B | 13.14%2.46B | 6.44%2.57B |
| -Dividend receivable | -58.56%99.1M | -60.60%94.19M | -49.90%195.97M | -39.08%302.78M | 342.40%239.15M | 339.48%239.07M | 5,027.82%391.14M | 1,834.68%497M | -10.00%54.06M | --54.4M |
| Advance payment | -69.97%2.16B | -38.95%1.95B | -45.73%3.12B | -0.82%3.63B | 28.23%7.2B | -17.52%3.19B | 86.54%5.75B | 14.80%3.66B | 62.92%5.62B | 57.36%3.87B |
| Inventories | 11.76%37.82B | 6.34%38.94B | 7.21%37.58B | 6.36%35.26B | 5.26%33.84B | 6.28%36.62B | 23.62%35.05B | 19.42%33.15B | 26.36%32.15B | 27.14%34.46B |
| Receivable financing | -28.02%1.67B | -15.28%1.97B | -19.50%1.56B | 0.59%1.57B | 49.01%2.31B | 42.57%2.32B | 35.04%1.94B | 7.52%1.56B | -3.63%1.55B | 0.52%1.63B |
| Non-current assets due within one year | 30.41%70.06M | 8.00%83.61M | -45.28%50.88M | -65.59%53.9M | -66.77%53.72M | -58.29%77.42M | 38.10%92.99M | 18.48%156.64M | 33.13%161.66M | 46.73%185.62M |
| Other current assets | 3.33%952.14M | -14.74%1.13B | 46.37%1.41B | 2.40%1.15B | 10.67%921.44M | 8.93%1.33B | 20.50%964.47M | 45.52%1.12B | 4.07%832.59M | 23.32%1.22B |
| Total current assets | 5.92%177.31B | 5.78%171.82B | 5.56%173.79B | 4.14%171.6B | 6.51%167.41B | 8.64%162.43B | 11.63%164.63B | 17.69%164.78B | 16.54%157.17B | 28.34%149.51B |
| Non Current assets | ||||||||||
| Other equity investment | -29.53%46.6M | -20.78%43.9M | 3.22%55.53M | 18.06%66.57M | 25.06%66.12M | -45.40%55.42M | 14.62%53.8M | 8.31%56.38M | -0.25%52.87M | 38.28%101.49M |
| Other non-current financial assets | -17.22%1.82B | -21.44%1.72B | 3.13%2.19B | 2.33%2.22B | 1.37%2.19B | 2.44%2.2B | 58.89%2.12B | 57.06%2.17B | 63.32%2.16B | 54.30%2.14B |
| Investment real estate | 5.79%355.96M | 16.31%366.01M | 14.21%340.38M | 38.49%332.45M | 48.93%336.48M | 27.70%314.67M | 45.25%298.04M | 18.54%240.06M | 9.31%225.93M | 15.51%246.42M |
| Long-term equity investment | -16.04%7.18B | -3.41%8.07B | -4.90%8.13B | -4.95%8.15B | -8.99%8.55B | -9.54%8.35B | -11.69%8.55B | -10.65%8.58B | -0.43%9.4B | 1.76%9.23B |
| Long term receivable account | 73.76%392.24M | 69.45%386.24M | 188.52%574.4M | 196.99%596.54M | 10.47%225.74M | 7.37%227.94M | -13.18%199.09M | 1.99%200.86M | -5.63%204.35M | 7.36%212.3M |
| Fixed assets | ---- | ---- | ---- | 4.45%11.81B | ---- | 5.34%12.16B | ---- | 12.67%11.31B | ---- | 10.06%11.54B |
| Constru in process | ---- | ---- | ---- | 25.76%4.37B | ---- | 28.53%3.57B | ---- | 2.00%3.47B | ---- | -4.69%2.78B |
| Productive biological assets | -2.64%132.38M | -0.03%133.38M | -0.02%133.9M | -0.27%134.88M | 0.61%135.97M | -2.74%133.43M | -66.53%133.93M | -66.29%135.25M | -66.40%135.14M | -65.92%137.19M |
| Intangible assets | -5.27%5.57B | -7.16%5.62B | -3.93%5.75B | -5.00%5.81B | -3.72%5.88B | -3.10%6.05B | 2.52%5.99B | 2.72%6.12B | 2.73%6.11B | 3.22%6.24B |
| Development expenditure | -39.86%184.56M | -30.65%215.32M | -41.47%220.2M | -38.98%222.05M | -9.20%306.87M | -9.37%310.51M | 20.51%376.21M | 28.06%363.92M | 39.57%337.97M | 32.16%342.61M |
| Goodwill | -2.38%11.12B | -2.17%11.15B | 0.22%11.41B | 0.05%11.39B | 0.49%11.39B | 0.51%11.39B | 1.29%11.38B | 1.31%11.39B | 0.83%11.33B | 0.86%11.34B |
| Long deferred expense | 13.24%522M | 12.61%534.57M | -14.15%437.41M | -15.71%435.84M | -2.58%460.97M | 2.65%474.71M | 33.10%509.53M | 33.41%517.07M | 12.83%473.16M | 7.77%462.44M |
| Deferred tax assets | -5.22%1.77B | -5.20%1.63B | 16.09%1.81B | 10.28%1.76B | 20.49%1.87B | 11.87%1.72B | 10.07%1.56B | 12.14%1.6B | 13.85%1.55B | 12.23%1.53B |
| Usufruct assets | -1.62%2.04B | -7.75%1.98B | 12.42%2.1B | 5.41%2.03B | 7.94%2.07B | 14.97%2.15B | -2.14%1.87B | -3.96%1.92B | -1.57%1.92B | -6.21%1.87B |
| Other non current assets | 17.43%451.86M | 9.69%483.38M | -18.29%307.42M | -14.63%400.51M | -4.70%384.8M | -0.70%440.69M | -13.75%376.22M | -17.28%469.15M | -45.93%403.79M | -48.21%443.8M |
| Total non current assets | -2.90%48.56B | -0.31%49.39B | 2.96%49.95B | 2.47%49.73B | 2.35%50.01B | 1.89%49.54B | 2.92%48.52B | 2.97%48.54B | 3.63%48.87B | 3.58%48.62B |
| Total assets | 3.89%225.87B | 4.36%221.21B | 4.97%223.74B | 3.76%221.34B | 5.52%217.42B | 6.98%211.97B | 9.52%213.15B | 13.98%213.32B | 13.19%206.04B | 21.23%198.13B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 14.70%42.91B | 7.04%38.06B | 10.61%38.81B | 20.12%40.51B | 15.76%37.41B | 28.14%35.56B | 19.68%35.08B | 16.29%33.72B | 17.92%32.32B | 23.26%27.75B |
| Notes payable and accounts payable | 5.27%60.37B | 8.88%59.48B | 4.72%61.69B | 4.08%58.46B | 7.18%57.35B | 5.95%54.63B | 19.68%58.91B | 25.47%56.16B | 24.83%53.51B | 22.79%51.57B |
| -Notes payable | 30.49%8.2B | 37.57%9.24B | 1.70%6.76B | 1.05%6.18B | 1.37%6.29B | 12.68%6.72B | 39.31%6.65B | 39.60%6.11B | 39.63%6.2B | 25.12%5.96B |
| -Accounts payable | 2.17%52.17B | 4.86%50.24B | 5.10%54.93B | 4.45%52.28B | 7.94%51.07B | 5.07%47.92B | 17.57%52.26B | 23.93%50.05B | 23.12%47.31B | 22.49%45.6B |
| Contract liabilities | -19.26%1.29B | -20.74%1.56B | 48.10%1.44B | -12.26%1.26B | -18.58%1.6B | -12.13%1.97B | -18.40%973.57M | 17.92%1.44B | 148.70%1.97B | 71.09%2.24B |
| Salaries payable | -1.69%1.28B | 0.69%1.8B | 13.60%1.59B | 0.87%1.43B | 13.06%1.3B | 12.88%1.78B | 16.45%1.4B | 27.87%1.41B | 19.73%1.15B | 10.29%1.58B |
| Taxs payable | 10.06%1.36B | 3.85%1.26B | -8.55%952.11M | -32.03%880.42M | -3.06%1.23B | -15.52%1.22B | 2.36%1.04B | 1.89%1.3B | -0.22%1.27B | -14.88%1.44B |
| Other payable (including interest and dividends) | -8.90%15.14B | -6.42%16.8B | 6.21%16.9B | -8.64%18.16B | 5.61%16.62B | 8.95%17.95B | 10.14%15.92B | 30.82%19.87B | 31.45%15.74B | 26.12%16.47B |
| -Dividend payable | -3.94%235.51M | 54.20%381.06M | -0.04%319.62M | -32.56%1.75B | -11.81%245.17M | -33.77%247.13M | 54.63%319.74M | 37.55%2.6B | -23.38%278.02M | 9.24%373.13M |
| Non current liabilities due within one year | -37.94%2.22B | -71.58%842.16M | -34.39%1.93B | -46.90%2.25B | 67.77%3.57B | -8.80%2.96B | 60.71%2.94B | 259.91%4.23B | 176.54%2.13B | 458.28%3.25B |
| Other current liabilities | 0.94%6.24B | -1.02%6.23B | 0.65%6.21B | -0.58%6.16B | -0.55%6.18B | -1.46%6.29B | -32.70%6.17B | -0.20%6.2B | -32.23%6.21B | -30.84%6.38B |
| Total current liabilities | 4.42%130.81B | 3.00%126.04B | 5.80%129.53B | 3.83%129.1B | 9.60%125.27B | 10.55%122.37B | 14.00%122.43B | 24.41%124.34B | 20.05%114.3B | 20.55%110.69B |
| Current liabilities | ||||||||||
| Long term loan | -0.01%6.62B | 43.99%8.33B | 2.70%7.69B | -3.94%6.6B | -22.98%6.62B | -7.57%5.79B | 13.21%7.49B | -10.81%6.87B | 21.79%8.6B | -12.55%6.26B |
| Long term account payable | ---- | ---- | ---- | ---- | ---- | --8.16M | ---- | ---- | ---- | ---- |
| Long term salaries pay | -3.09%35.95M | 0.71%39.16M | -34.41%25.16M | 27.62%49.5M | -2.50%37.1M | -0.07%38.88M | 2.12%38.35M | 0.98%38.79M | 2.13%38.05M | -0.24%38.91M |
| Estimate liabilities | 1.77%36.52M | -8.99%36.03M | 51.22%40.52M | 41.81%37.23M | 49.46%35.88M | 65.08%39.59M | -46.38%26.8M | -48.30%26.26M | 3.28%24.01M | 3.16%23.98M |
| Deferred tax liabilities | -21.06%788.19M | -19.63%816.45M | -5.56%876.71M | -0.14%984.21M | 1.56%998.51M | -3.18%1.02B | -20.84%928.28M | -15.56%985.58M | -0.05%983.17M | 5.05%1.05B |
| Long term deferred income | -14.09%543.95M | -13.02%550.99M | 9.53%589.68M | 11.35%626.65M | 12.38%633.16M | 18.50%633.48M | 17.08%538.35M | 13.39%562.76M | -75.38%563.42M | -77.24%534.58M |
| Lease liabilities | -3.44%1.46B | -9.92%1.4B | 23.31%1.62B | 13.23%1.5B | 8.02%1.51B | 19.09%1.55B | -23.35%1.31B | -9.82%1.32B | -1.43%1.4B | -9.25%1.3B |
| Other non current liabilities | 24.59%259.01M | 23.16%249.26M | -13.26%201.73M | -9.82%200.09M | -12.57%207.9M | -10.16%202.4M | -9.08%232.58M | -12.59%221.87M | -19.43%237.79M | -1.05%225.29M |
| Total non current liabilities | -2.98%9.76B | 23.23%11.43B | 4.53%11.05B | -0.32%10B | -15.14%10.06B | -1.77%9.27B | -0.29%10.57B | -12.66%10.04B | -4.64%11.85B | -24.74%9.44B |
| Total liabilities | 3.87%140.57B | 4.42%137.47B | 5.70%140.58B | 3.52%139.11B | 7.27%135.33B | 9.58%131.65B | 12.71%133B | 20.59%134.38B | 17.20%126.15B | 15.10%120.13B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.14%3.71B | 0.13%3.71B | 0.04%3.7B | 0.01%3.7B | 0.13%3.7B | 0.16%3.7B | 0.19%3.7B | 0.18%3.7B | 0.08%3.7B | 30.10%3.7B |
| Capital reserve funds | 1.60%29.66B | 1.58%29.65B | 0.53%29.32B | 0.34%29.26B | 0.25%29.19B | 0.31%29.19B | -0.41%29.17B | -0.14%29.16B | -0.19%29.11B | 81.06%29.1B |
| Surplus reserve funds | 0.00%2.31B | 0.00%2.31B | 6.86%2.31B | 6.86%2.31B | 6.86%2.31B | 6.86%2.31B | 8.35%2.16B | 8.35%2.16B | 8.35%2.16B | 8.35%2.16B |
| Retained profit | 7.11%37.88B | 8.06%36.55B | 6.01%36.06B | 7.36%35.25B | 4.02%35.36B | 4.13%33.82B | 7.29%34.02B | 6.80%32.83B | 13.90%34B | 13.57%32.48B |
| Other composite income | -7.88%-540.46M | -7.70%-534.28M | 1.45%-530.94M | -6.07%-528.5M | -24.66%-501M | -33.60%-496.09M | -5.68%-538.76M | -62.42%-498.24M | -117.35%-401.88M | -157.16%-371.32M |
| Shareholders equity without minority interests | 4.21%73.01B | 4.60%71.68B | 3.44%70.87B | 3.91%69.99B | 2.18%70.06B | 2.18%68.52B | 3.53%68.51B | 3.11%67.36B | 6.27%68.57B | 35.87%67.06B |
| Minority interests | 2.22%12.29B | 2.24%12.07B | 5.66%12.29B | 5.65%12.24B | 6.28%12.02B | 7.88%11.8B | 11.43%11.63B | 11.48%11.58B | 14.78%11.31B | 12.70%10.94B |
| Total shareholder equity | 3.92%85.3B | 4.25%83.74B | 3.76%83.16B | 4.16%82.23B | 2.76%82.09B | 2.98%80.33B | 4.60%80.14B | 4.26%78.94B | 7.40%79.88B | 32.06%78B |
| Total liabilityies and equity | 3.89%225.87B | 4.36%221.21B | 4.97%223.74B | 3.76%221.34B | 5.52%217.42B | 6.98%211.97B | 9.52%213.15B | 13.98%213.32B | 13.19%206.04B | 21.23%198.13B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) | -- | -- | -- | PricewaterhouseCoopers Zhongtian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.